Healthcare
Live Price
Offline$0.05
+0.00% today
1Y Change
-97.51%
Window
Jun 26, 2025 โ Jun 25, 2026
Coverage: 249 bars ยท Jun 26, 2025 โ Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Elbit Imaging Ltd. (EMITF) is a Healthcare stock with a market cap of $80.00M and listed on OTC. The stock last traded around $0.05 and down 97.5% across the available one-year price window (Jun 26, 2025 โ Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +24.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +24.0%, free cash flow -1138.7% with operating margin 0.0% and ROIC -3.6%. Stock Foundry combines EMITF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on May 1, 2025, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +24.0%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 May 1, 2025 | โ | +0.0% | +0.0% | -8.0% |
2024 Sep 30, 2024 | โ | +0.0% | +0.0% | -8.0% |
2024 Jun 30, 2024 | โ | +0.0% | +0.0% | -8.0% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EMITF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EMITF Max Drawdown
-97.67%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for EMITF and SPY.

Company Overview
Elbit Imaging Ltd.
Other OTC
Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.